跳至主要内容
临床试验/ACTRN12609000317291
ACTRN12609000317291招募中未知

Do people with psychosis taking Risperdal Consta, who participate in Collaborative Therapy, compared to people with psychosis taking Risperdal Consta and treatment as usual, have improved treatment compliance?

Prof. David Castle0 个研究点目标入组 200 人开始时间: 2009年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Age 18 – 65 years
  • Currently taking Risperdal Consta (must have been on consta for a minimum of 6 weeks).
  • Able to converse in English without an interpreter
  • Absence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention.

排除标准

  • Age under 18 years
  • Not taking Risperdal Consta
  • Unable to converse in English without an interpreter
  • Presence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention

研究者

发起方
Prof. David Castle

相似试验